Angion Biomedica Corp. Human Resources Contracts & Agreements
28 Contracts & Agreements
- Bonus & Incentive Agreements (11 contracts)
- Compensation Agreements (5)
- Consulting Agreements (5)
- Employment Agreements (4)
- Separation Agreements (3)
- Non-Employee Director Compensation Program (Filed With SEC on November 13, 2023)
- Angion Biomedica Corp. Retention Bonus Plan (Filed With SEC on February 13, 2023)
- Amended and Restated Executive Separation Benefits Plan dated November 19, 2021 (Filed With SEC on March 30, 2022)
- Non-Employee Director Compensation Program (Filed With SEC on March 30, 2022)
- Third Amendment dated March 17, 2022 to Consulting Agreement, dated June 3, 2020, as amended, by and between Angion Biomedica Corp. and Gregory S. Curhan (Filed With SEC on March 30, 2022)
- Second Amendment dated December 1, 2021 to Consulting Agreement, dated June 3, 2020, as amended, by and between Angion Biomedica Corp. and Gregory S. Curhan (Filed With SEC on March 30, 2022)
- First Amendment dated September 9, 2022 to Consulting Agreement, dated June 3, 2020, as amended, by and between Angion Biomedica Corp. and Gregory S. Curhan (Filed With SEC on March 30, 2022)
- Separation Agreement, dated March 1, 2022, by and between Angion Biomedica Corp. and Elisha Goldberg (Filed With SEC on March 30, 2022)
- Separation Agreement, dated February 25, 2022, by and between Angion Biomedica Corp. and Itzhak D. Goldberg (Filed With SEC on March 30, 2022)
- ANGION BIOMEDICA CORP. NON-EMPLOYEE DIRECTOR COMPENSATION PROGRAM (Filed With SEC on February 1, 2021)
- Form of Restricted Stock Unit Award Grant Notice and Restricted Stock Unit Award Agreement under the 2021 Incentive Award Plan (Filed With SEC on February 1, 2021)
- Form of Restricted Stock Award Grant Notice and Restricted Stock Award Agreement under the 2021 Incentive Award Plan (Filed With SEC on February 1, 2021)
- Form of Stock Option Grant Notice and Stock Option Agreement under the 2021 Incentive Award Plan (Filed With SEC on February 1, 2021)
- 2021 Incentive Award Plan (Filed With SEC on February 1, 2021)
- Non-Employee Director Compensation Program (Filed With SEC on January 15, 2021)
- Consulting Agreement, dated June 3, 2020, as amended, by and between Angion Biomedica Corp. and Greg Curhan (Filed With SEC on January 15, 2021)
- Executive Employment Agreement, dated December 17, 2018, by and between Angion Biomedica Corp. and John F. Neylan (Filed With SEC on January 15, 2021)
- Executive Employment Agreement, dated May 1, 2018, by and between Angion Biomedica Corp. and Itzhak D. Goldberg (Filed With SEC on January 15, 2021)
- Amended and Restated Employment Agreement, dated March 29, 2019, by and between Angion Biomedica Corp. and Jay R. Venkatesan (Filed With SEC on January 15, 2021)
- Form of Stock Option Exercise under 2015 Equity Incentive Plan (Filed With SEC on January 15, 2021)
- Form of Non-Qualified Stock Option Grant under 2015 Equity Incentive Plan (Filed With SEC on January 15, 2021)
- Form of Incentive Stock Option Grant under 2015 Equity Incentive Plan (Filed With SEC on January 15, 2021)
- Second Amended and Restated 2015 Equity Incentive Plan (Filed With SEC on January 15, 2021)
- EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on May 23, 2014)
- ANGION BIOMEDICA CORP. 2014 NON-EMPLOYEEDIRECTOR COMPENSATION POLICY (Filed With SEC on May 23, 2014)
- CONSULTING AGREEMENT (Filed With SEC on April 14, 2014)
- ANGION BIOMEDICA CORP. Stock Option Grant Notice Stock Option Grant under the Company’s 2014 Equity Incentive Plan (Filed With SEC on April 14, 2014)
- ANGION BIOMEDICA CORP. 2014 EQUITY INCENTIVE PLAN (Filed With SEC on April 14, 2014)
